Novarex노바렉스
194700 · KOSDAQ · ₩194700 · 노바렉스
₩8,970▼ ₩170 (1.86%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 17.4% | 16.9% | 13.9% | 14.3% | 14.2% | 14.8% |
| Operating margin | 11.0% | 10.4% | 7.3% | 8.5% | 9.0% | 10.8% |
| Net margin | 9.8% | 8.7% | 7.5% | 7.3% | 7.1% | 9.5% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +8.3% | +36.1% | −1.7% | +7.3% | +0.9% | — |
| Operating income growth | +14.9% | +93.6% | −15.5% | +1.1% | −15.7% | — |
| Net income growth | +22.3% | +56.5% | +1.1% | +10.1% | −24.0% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 16.4% | 14.8% | 10.6% | 11.6% | 12.5% | 18.9% |
| Return on assets | 11.7% | 10.8% | 8.1% | 8.3% | 7.7% | 10.4% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 40.1% | 41.5% | 31.5% | 31.8% | 48.9% | 81.5% |
| Net debt to equity | −6.2% | −5.6% | −3.6% | −3.4% | 3.6% | 25.0% |
| Current ratio | 249.2% | 223.5% | 213.4% | 203.0% | 178.4% | 124.4% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Novarex / 노바렉스 / 194700 / KRX:194700
Source: KRX statistical information